Marksans Pharma Ltd (MARKSANS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 604869, "name": "Marksans Pharma", "stock_name": "Marksans Pharma", "full_name": "Marksans Pharma Ltd", "name_url": "stocks-analysis/marksans-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "335.30", "chg": 2.7, "chgp": "0.81%", "dir": 1, "prev_price": "332.60", "mcapval": "15,194.58 Cr", "mcap": "Small Cap", "scripcode": 524404, "symbol": "MARKSANS", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE750C01026", "curr_date": "Sep 23, 09:37 AM", "curr_time": "09:38 AM", "last_traded_at": "Sep 23, 09:37 AM IST", "bse_nse_vol": "79.67 k", "exc_status": "Active", "traded_date": "Sep 23, 2026", "traded_date_str": "2026 09 23", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/marksans-pharma-604869-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Marksans Pharma Ltd is Rated Buy by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/marksans-pharma-ltd-is-rated-buy-by-marketsmojo-4199749", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/MarksansPharmaL_mojoScore_4199749.png", "date": "2026-09-21 10:10:31", "description": "Marksans Pharma Ltd is rated Buy by MarketsMOJO, with this rating last updated on 27 July 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 September 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "Marksans Pharma Gains 0.57%: 2 Key Factors Driving the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-gains-057-2-key-factors-driving-the-week-4191532", "imagepath": "", "date": "2026-09-12 15:04:55", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>07 Sep:</strong> Stock opens strong at Rs.335.15 (+2.67%) despite Sensex decline</p>\n <p><strong>08 Sep:</strong> Marksans Pharma hits new 52-week high at Rs.349.7</p>\n <p><strong>08 Sep:</strong> Multibagger returns highlighted amid strong financial performance</p>\n <p><strong>09-11 Sep:</strong> Price consolidates with mild declines, closing at Rs.328.30</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.326.45</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close..." }, { "title": "Marksans Pharma Ltd is Rated Buy by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/marksans-pharma-ltd-is-rated-buy-by-marketsmojo-4189262", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/MarksansPharmaL_mojoScore_4189262.png", "date": "2026-09-10 10:10:26", "description": "Marksans Pharma Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 27 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 September 2026, providing investors with the latest insights into its performance and outlook." }, { "title": "100.41% Return vs 6.97% Profit Growth: What Powers Marksans Pharma Ltd’s Multibagger Rally?", "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-ltd-delivers-multibagger-returns-amid-robust-financial-performance-4186561", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/MarksansPharmaL_multibagger_4186561.png", "date": "2026-09-08 10:10:06", "description": "A 100.41% stock return in one year. A 6.97% growth in net profit over the same period. The gap between those two numbers — roughly 93 percentage points — is driven largely by the market’s willingness to pay more for each rupee of Marksans Pharma Ltd’s earnings. That willingness is the story behind this multibagger performance." }, { "title": "Broad-Based Technical Strength Lifts Marksans Pharma Ltd to 52-Week High of Rs 349.7", "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-ltd-hits-new-52-week-high-at-rs3497-4186223", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/MarksansPharmaL_priceRelatedfactors_4186223.png", "date": "2026-09-08 09:56:43", "description": "Surging past its previous peaks, Marksans Pharma Ltd touched a fresh 52-week high of Rs 349.7 on 8 Sep 2026, marking a remarkable 101.7% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained price strength, even as the broader market struggles to find footing." }, { "title": "Marksans Pharma Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/marksans-pharma-ltd-is-rated-buy-4174931", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/MarksansPharmaL_mojoScore_4174931.png", "date": "2026-08-30 10:10:14", "description": "Marksans Pharma Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 27 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 August 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Marksans Pharma Declines 3.53% Despite Mojo Upgrade and 52-Week High", "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-declines-353-despite-mojo-upgrade-and-52-week-high-4165501", "imagepath": "", "date": "2026-08-22 16:08:08", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>17 Aug:</strong> New 52-week high of Rs.345.7 reached</p>\n <p><strong>17 Aug:</strong> Mojo Grade upgraded to Buy, robust trading activity</p>\n <p><strong>20 Aug:</strong> Sharp decline of 2.09% amid broader market gains</p>\n <p><strong>21 Aug:</strong> Week closes at Rs.321.25, down 0.31% on the day</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.333.00</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.321.25</div><div class=\"..." }, { "title": "Marksans Pharma Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/marksans-pharma-ltd-is-rated-buy-4161134", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/MarksansPharmaL_mojoScore_4161134.png", "date": "2026-08-19 10:10:33", "description": "Marksans Pharma Ltd is rated Buy by MarketsMOJO, with this rating last updated on 27 July 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 19 August 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and technical outlook." }, { "title": "Marksans Pharma Ltd Sees Robust Trading Activity Amid Upgraded Mojo Grade", "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-ltd-sees-robust-trading-activity-amid-upgraded-mojo-grade-4157445", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/MarksansPharmaL_most_active_equities_by_value_4157445.png", "date": "2026-08-17 10:00:07", "description": "Marksans Pharma Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed significant trading activity and institutional interest, buoyed by a recent upgrade in its MarketsMOJO Mojo Grade from Hold to Buy. The stock’s strong value turnover, rising investor participation, and technical momentum position it as a noteworthy contender in the current market landscape." } ], "total": 422, "sid": "604869", "stock_news_url": "https://www.marketsmojo.com/news/marksans-pharma-604869" }, "announcements": [ { "caption": "Special Window For Re-Lodgement Of Transfer Requests Of Physical Shares", "datetime": "17-Sep-2026", "details": "Notice to Shareholders regarding re-opening of Special Window for Re-lodgement of transfer requests of Physical Shares", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "07-Sep-2026", "details": "Copy of Newspaper Publication regarding transfer of unclaimed dividend and equity shares of the Company to the IEPF", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation", "datetime": "01-Sep-2026", "details": "Intimation of schedule of Investors Meet", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Marksans Pharma Ltd has declared <strong>90%</strong> dividend, ex-date: 20 Aug 26", "dt": "2026-08-20", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Marksans Pharma Ltd has announced <strong>1:10</strong> stock split, ex-date: 11 Mar 08", "dt": "2008-03-11", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

07 Sep: Stock opens strong at Rs.335.15 (+2.67%) despite Sensex decline

08 Sep: Marksans Pharma hits new 52-week high at Rs.349.7

08 Sep: Multibagger returns highlighted amid strong financial performance

09-11 Sep: Price consolidates with mild declines, closing at Rs.328.30

Week Open

Rs.326.45

Week Close...

Read full news article

Marksans Pharma Ltd is Rated Buy by MarketsMOJO

2026-09-10 10:10:26

Marksans Pharma Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 27 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 September 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

100.41% Return vs 6.97% Profit Growth: What Powers Marksans Pharma Ltd’s Multibagger Rally?

2026-09-08 10:10:06

A 100.41% stock return in one year. A 6.97% growth in net profit over the same period. The gap between those two numbers — roughly 93 percentage points — is driven largely by the market’s willingness to pay more for each rupee of Marksans Pharma Ltd’s earnings. That willingness is the story behind this multibagger performance.

Read full news article

Broad-Based Technical Strength Lifts Marksans Pharma Ltd to 52-Week High of Rs 349.7

2026-09-08 09:56:43

Surging past its previous peaks, Marksans Pharma Ltd touched a fresh 52-week high of Rs 349.7 on 8 Sep 2026, marking a remarkable 101.7% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained price strength, even as the broader market struggles to find footing.

Read full news article

Marksans Pharma Ltd is Rated Buy

2026-08-30 10:10:14

Marksans Pharma Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 27 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 August 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Marksans Pharma Declines 3.53% Despite Mojo Upgrade and 52-Week High

2026-08-22 16:08:08

Key Events This Week

17 Aug: New 52-week high of Rs.345.7 reached

17 Aug: Mojo Grade upgraded to Buy, robust trading activity

20 Aug: Sharp decline of 2.09% amid broader market gains

21 Aug: Week closes at Rs.321.25, down 0.31% on the day

Read full news article

Marksans Pharma Ltd is Rated Buy

2026-08-19 10:10:33

Marksans Pharma Ltd is rated Buy by MarketsMOJO, with this rating last updated on 27 July 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 19 August 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and technical outlook.

Read full news article

Marksans Pharma Ltd Sees Robust Trading Activity Amid Upgraded Mojo Grade

2026-08-17 10:00:07

Marksans Pharma Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed significant trading activity and institutional interest, buoyed by a recent upgrade in its MarketsMOJO Mojo Grade from Hold to Buy. The stock’s strong value turnover, rising investor participation, and technical momentum position it as a noteworthy contender in the current market landscape.

Read full news article

View All News